CAROLINE L RUBIN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FRESNO, CA NPI 1124559596
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CA Smith & Nephew, Inc. All categories
General Payments — all program years on this page
$1,331.73
- Category: General Payments
- Program years: PY2021–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $326.62 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.62 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Smith & Nephew, Inc. | $208.82 | 3 |
| Amgen Inc. | $41.72 | 2 |
| SCPHARMACEUTICALS INC. | $33.93 | 2 |
| Daiichi Sankyo Inc. | $25.66 | 1 |
| Acerta Pharma LLC | $16.49 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089476409 | Daiichi Sankyo Inc. | $25.66 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105494171 | AstraZeneca Pharmaceuticals LP | $16.49 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116071859 | Amgen Inc. | $18.71 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116071867 | Amgen Inc. | $23.01 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132255369 | SCPHARMACEUTICALS INC. | $17.75 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132264357 | SCPHARMACEUTICALS INC. | $16.18 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149612954 | Smith+Nephew, Inc. | $15.87 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149612956 | Smith+Nephew, Inc. | $65.53 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149612958 | Smith+Nephew, Inc. | $127.42 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.